Saltar al contenido
Merck

Effect of non-thermal radiofrequency on body temperature in mice.

Scientific reports (2020-04-03)
Thi Cuc Mai, Stéphane Delanaud, Véronique Bach, Anne Braun, Amandine Pelletier, René de Seze
RESUMEN

Communication technologies based on radiofrequency (RF) propagation bring great benefits to our daily life. However, their rapid expansion raises concerns about possible impacts on public health. At intensity levels below the threshold to produce thermal effects, RF exposure has also recently been reported to elicit biological effects, resembling reactions to cold. The objective of the present study was to investigate the effects of non-thermal RF on body temperature in mice and the related mechanisms. 3-months-old C57BL/6 J mice were exposed to a continuous RF signal at 900 MHz, 20 ± 5 V.m-1 for 7 consecutive days, twice per day during the light phase, for one hour each time. The SAR was 0.16 ± 0.10 W.kg-1. We showed that body temperature patterns in mice change synchronously with the RF exposure periods. Average body temperature in the light phase in the exposed group was higher than in the control group. The expression of the TRPM8 gene was not affected by RF in trigeminal ganglia. Furthermore, the injection of a TRPM8 antagonist did not induce a temperature decrease in exposed mice, as this was the case for sham-controls. These findings indicate that 900 MHz RF exposure at non-thermal level produce a physiological effect on body temperature in mice. However, the involvement of TRPM8 receptors in the mechanism by which RF induced changes in body temperature of mice which remains to be further explored. It must then be assessed if this effect is extrapolable to man, and if this could lead to consequences on health.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Persulfato de amonio, for molecular biology, suitable for electrophoresis, ≥98%
Sigma-Aldrich
N,N,N′,N′-Tetrametiletilendiamina, BioReagent, suitable for electrophoresis, ≥99.0%
Sigma-Aldrich
Acrilamida/bisacrilamida, al 30% solution, BioReagent, suitable for electrophoresis, 29:1